Early-onset myasthenia gravis: A recurring T-cell epitope in the adult- specific acetylcholine receptor ε subunit presented by the susceptibility allele HLA-DR52a

Annals of Neurology

Volumn 45, Issue 2, 1999, Pages 224-231

  Hill, Marguerite ^a   Beeson, David ^a   Moss, Paul ^a   Jacobson, Leslie ^a   Bond, Alison ^a   Corlett, Louise ^a   Newsom Davis, John ^a   Vincent, Angela ^a   Willcox, Nick ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR; EPITOPE; HLA A1 ANTIGEN; HLA ANTIGEN; HLA B8 ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN; PENICILLAMINE; RECEPTOR SUBUNIT; RECOMBINANT PROTEIN; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MYASTHENIA GRAVIS; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR GENE; T LYMPHOCYTE;

AMINO ACID SEQUENCE; BASE SEQUENCE; EPITOPES, T-LYMPHOCYTE; HUMANS; MOLECULAR SEQUENCE DATA; MYASTHENIA GRAVIS; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, CHOLINERGIC; TIME FACTORS;

EID: 0033043998     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199902)45:2<224::AID-ANA13>3.0.CO;2-B     Document Type: Article

References (48)

1. Drachman DB. Myasthenia gravis. N Engl J Med 1994;1797-1810
2. Lindstrom J, Shelton D, Fujii Y. Myasthenia gravis. Adv Immunol 1988;42:233-284
3. Willcox N. Myasthenia gravis. Curr Opin Immunol 1993;5: 910-917
4. Scadding GK, Vincent A, Newsom-Davis J, Henry K. Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology. Neurology 1981;31:935-943
5. Compston DAS, Vincent A, Newsom-Davis J, Batchelor JR. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 1980;103:579-601
6. Degli-Esposti MA, Andreas A, Christiansen FT, et al. An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics 1992;35:355-364
7. Tzartos SJ, Kokla A, Walgrave SL, Conti-Tronconi BM. Localization of the main immunogenic region of human muscle acetylcholine receptor to residues 67-76 of the α subunit. Proc Natl Acad Sci USA 1988;85:2899-2903
8. Vincent A, Newsom-Davis J. Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles. Clin Exp Immunol 1982;49:257-265
9. Schluep M, Willcox N, Vincent A, et al. Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study. Ann Neurol 1987;22:212-222
10. MacLennan C, Beeson D, Buijs A-M, et al. Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis. Ann Neurol 1997;41:423-431
11. Protti MP, Manfredi AA, Horton RM, et al. Myasthenia gravis: recognition of a human autoantigen at the molecular level. Immunol Today 1993;14:363-368
12. Hawke S, Matsuo H, Nicolle M, et al. Autoimmune T cells in myasthenia gravis: heterogeneity and potential for specific immunotargeting. Immunol Today 1996;17:307-311
13. 86 HLA-DRβ dimorphism in autoantigen presentation to human T cells. Proc Natl Acad Sci USA 1991;88:7343-7347
14. Garlepp MJ, Dawkins RL, Christiansen FT. HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis. BMJ 1983;286:338-340
15. Vincent A, Newsom-Davis J. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset. Clin Exp Immunol 1982;49:266-272
16. Heidenreich F, Vincent A, Newsom-Davis J. Differences in fine specificity of anti-acetylcholine receptor antibodies between subgroups of spontaneous myasthenia gravis of recent onset, and of peniciliamine-induced myasthenia. Autoimmunity 1988; 2:31-37
17. Beeson D, Brydson M, Betty M, et al. Primary structure of the human muscle acetylcholine receptor: cDNA cloning of the γ and ε subunits. Eur J Biochem 1993;215:229-238
18. Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JW. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 1990;185:60-89
19. Beeson D, Morris A, Vincent A, Newsom-Davis J. The human muscle nicotinic acetylcholine receptor α-subunit exists as two isoforms: a novel exon. EMBO J 1990;9:2101-2106
20. Matsuo H, Batocchi A-P, Hawke S, et al. Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine reccptor. J Immunol 1995;155:3683-3692
21. Hawke S, Willcox N, Harcourt G, et al. Stimulation of human T cells by sparse antigens captured on immunomagnetic particles. J Immunol Methods 1992;155:41-48
22. Beeson D, Amar M, Bermudez I, et al. Stable functional expression of the adult subtype of human muscle acetylcholine receptor following transfection of the human rhabdomyosarcoma cell line TE671 with cDNA encoding the ε subunit. Neurosci Lett 1996;207:57-60
23. Moss PAH, Rosenberg WMC, Zintzaras E, Bell JI. Characterisation of the human T cell receptor α chain repertoire and demonstration of genetic influence on Vα usage. Eur J Immunol 1993;23:1153-1159
24. Posnett DN, Wang CY, Friedman SM. Inherited polymorphism of the human T-cell antigen receptor detected by monoclonal antibody. Proc Natl Acad Sci USA 1986;83:7888-7892
25. Callan MFC, Reyburn HT, Bowness P, et al. A method for producing monoclonal antibodies to human T-cell-receptor β-chain variable regions. Proc Natl Acad Sci USA 1993;90: 10454-10458
26. Wu S, Maslanka K, Gorski J. An integrin polymorphism that defines reactivity with alloantibodies generates an anchor for MHC class II peptide binding. A model for unidirectional alloimmune responses. J Immunol 1997;158:3221-3226
27. Nagvekar N, Corlett L, Jacobson LW, et al. Scanning a DRB3*0101 (DR52a)-restricted epitope cross-presented by DR3: overlapping natural and artificial determinants of human acetylcholine receptor. J Immunol 1999 (in press)
28. Vieira ML, Caillat-Zucman, Gajdos P, et al. Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis. J Neuroimmunol 1993;47:115-122
29. Vincent A, Willcox N, Hill M, et al. Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis. Immunol Rev 1998;164:157-168
30. Vincent A, Jacobson L, Shillito P, Response to human acetylcholine receptor α 138-199: determinant spreading initiates autoimmunity to self-antigen in rabbits. Immunol Lett 1994;39: 269-275
31. Lehmann PV, Sercarz EE, Forsthuber T, et al. Determinant spreading and the dynamics of the autoimmune T cell repertoire. Immunol Today 1993;14:203-208
32. Bond AP, Corlett L, Curnow JS, et al. Diverse patterns of unresponsiveness in an acetylcholine receptor-specific T-cell clone from a myasthenia gravis patient after engaging the T-cell receptor with three different ligands. J Neuroimmunol 1998;82: 182-190
33. Engel AG, Lambert EH, Howard FM. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis. Ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin Proc 1977;52:267-280
34. Moiola L, Galbiati F, Martino G, et al. IL-12 is required for the induction of experimental myasthenia gravis, an antibody-mediated disease. Eur J Immunol 1998;28:2487-2497
35. Balasa B, Deng C, Lee J, et al. Interferon γ (IFN γ) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice. J Exp Med 1997;186:385-391
36. Oosterhuis HJGH. Myasthenia gravis. Groningen: Groningen Neurological Press, 1997
37. Piccinni M-P, Giudizi M-G, Biagiotti R, et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995;155:128-133
38. Jolicoeur C, Hanahan D, Smith KM. T-cell tolerance toward a transgenic β-cell antigen and transcription of endogenous pancreatic genes in thymus. Proc Natl Acad Sci USA 1994;91: 6707-6711
39. Alderuccio F, Gleeson PA, Berzins SP, et al. Expression of the gastric H/K-ATPase α-subunit in the thymus may explain the dominant role of the β-subunit in the pathogenesis of autoimmune gastritis. Autoimmunity 1997;25:167-175
40. Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987;49:273-280
41. Saoudi A, Seddon B, Heath V, et al. The physiological role of regulatory T cells in the prevention of autoimmunity: the function of the thymus in the generation of the regulatory T cell subset. Immunol Rev 1996;149:195-216
42. MacLennan CA, Beeson D, Willcox N, et al. Muscle nicotinic acetylcholine receptor RNA-expression in hyperplastic and neoplastic myasthenia gravis thymus. Ann NY Acad Sci 1998;841: 407-410
43. Berdoz J, Gorski J, Termijtelen A-M, et al. Constitutive and induced expression of the individual HLA-DRβ and α chain loci in different cell types. J Immunol 1987;139:1336-1341
44. 4 lymphocytes by soluble major histocompatibility complex class II-peptide complexes. J Clin Invest 1994;93: 1361-1369
45. ul. J Immunol 1992;148: 3049-3054
46. Acha-Orbea H, Mitchell DJ, Timmermann L, et al. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune deviation. Cell 1988;54:263-273
47. Waisman A, Ruiz PJ, Hirschberg DL, et al. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat Med 1996;2:899-905
48. McHeyzer-Williams G, Altman JD, Davis MM. Tracking antigen-specific helper T cell responses. Curr Opin Immunol 1996;8:278-284